White label – Pompe disease - ClinicalTrials.eu

Study of Zanubrutinib and Obinutuzumab for Patients with Relapsed or Refractory Follicular Lymphoma

Not recruiting

2 1 1 1
Investigated Diseases:
- Follicular lymphoma
Investigated Drugs:
- Obinutuzumab
- Zanubrutinib
Study on Encorafenib, Cetuximab, and FOLFIRI for Patients with BRAF V600E Mutated Metastatic Colorectal Cancer After Progression on Encorafenib and Cetuximab

Not recruiting

2 1 1 1
Investigated Diseases:
- Colorectal adenocarcinoma
Investigated Drugs:
Study on the Safety and Effectiveness of Fingolimod and Interferon Beta-1a in Children with Multiple Sclerosis

Not recruiting

3 1 1 1
Investigated Drugs:
- Fingolimod
Study on the Safety and Effectiveness of Rilzabrutinib for Adults and Adolescents with Persistent or Chronic Immune Thrombocytopenia (ITP)

Not recruiting

3 1
Investigated Diseases:
- Immune thrombocytopenia
Investigated Drugs:
- Rilzabrutinib
+1
Study of Ixekizumab Treatment Effects on Joint and Bone Inflammation in Patients with Axial Spondyloarthritis and Psoriatic Arthritis Using Advanced Imaging Methods

Not recruiting

3 1 1 1
Investigated Drugs:
- Ixekizumab
Study on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment

Not recruiting

3 1 1 1
Investigated Diseases:
- Bladder transitional cell carcinoma
Investigated Drugs:
- Cetrelimab
- Gemcitabine Hydrochloride
+3
Study Comparing Nivolumab, Nivolumab with Ipilimumab, or Chemotherapy for Patients with Metastatic Colorectal Cancer with High Microsatellite Instability

Not recruiting

3 1 1 1
Investigated Diseases:
- Colorectal cancer metastatic
Investigated Drugs:
+6
A Phase 4 Study of Crizanlizumab Treatment for Patients with Sickle Cell Disease Who Previously Participated in Novartis Clinical Trials

Not recruiting

3 1 1
Investigated Drugs:
- Crizanlizumab
Study on Baxdrostat for Lowering Blood Pressure in Patients with Resistant Hypertension

Not recruiting

3 1
Investigated Drugs:
- Baxdrostat
+3
Study on Axatilimab for Patients with Idiopathic Pulmonary Fibrosis

Not recruiting

2 1
Investigated Drugs:
- Axatilimab
+2

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies